242 related articles for article (PubMed ID: 33389291)
1. Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype.
Tadros AB; Sevilimedu V; Giri DD; Zabor EC; Morrow M; Plitas G
Ann Surg Oncol; 2021 Aug; 28(8):4245-4253. PubMed ID: 33389291
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
3. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
4. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival.
Narayan P; Kostrzewa CE; Zhang Z; O'Brien DAR; Mueller BA; Cuaron JJ; Xu AJ; Bernstein MB; McCormick B; Powell SN; Khan AJ; Wen HY; Braunstein LZ
Breast Cancer Res Treat; 2023 Jun; 199(2):355-361. PubMed ID: 36976395
[TBL] [Abstract][Full Text] [Related]
6. Metaplastic breast cancer: Prognostic and therapeutic considerations.
Corso G; Frassoni S; Girardi A; De Camilli E; Montagna E; Intra M; Bottiglieri L; Margherita De Scalzi A; Fanianos DM; Magnoni F; Invento A; Toesca A; Conforti F; Bagnardi V; Viale G; Colleoni MA; Veronesi P
J Surg Oncol; 2021 Jan; 123(1):61-70. PubMed ID: 33047318
[TBL] [Abstract][Full Text] [Related]
7. A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma.
Cimino-Mathews A; Verma S; Figueroa-Magalhaes MC; Jeter SC; Zhang Z; Argani P; Stearns V; Connolly RM
Am J Clin Pathol; 2016 Mar; 145(3):365-72. PubMed ID: 27124919
[TBL] [Abstract][Full Text] [Related]
8. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
[TBL] [Abstract][Full Text] [Related]
9. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
Ong CT; Campbell BM; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hall A; Hyslop T; Hwang ES; Fayanju OM
Ann Surg Oncol; 2018 Aug; 25(8):2249-2260. PubMed ID: 29855830
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors on outcomes in metaplastic breast cancer.
Leyrer CM; Berriochoa CA; Agrawal S; Donaldson A; Calhoun BC; Shah C; Stewart R; Moore HCF; Tendulkar RD
Breast Cancer Res Treat; 2017 Oct; 165(3):499-504. PubMed ID: 28689362
[TBL] [Abstract][Full Text] [Related]
11. The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer.
Hu J; Lang R; Zhao W; Jia Y; Tong Z; Shi Y
Breast Cancer Res Treat; 2023 Jul; 200(1):23-36. PubMed ID: 37160814
[TBL] [Abstract][Full Text] [Related]
12. Metaplastic breast cancer: clinicopathological features and its prognosis.
Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
[TBL] [Abstract][Full Text] [Related]
13. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
[TBL] [Abstract][Full Text] [Related]
14. Multimodality imaging and histopathology of metaplastic breast cancer.
Çelik H; Başara Akın I; Durak MG; Balcı P
Diagn Interv Radiol; 2023 Jan; 29(1):59-67. PubMed ID: 36959869
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US.
Elimimian EB; Samuel TA; Liang H; Elson L; Bilani N; Nahleh ZA
JAMA Netw Open; 2021 Apr; 4(4):e214123. PubMed ID: 33844001
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of metaplastic breast carcinoma: A single-center experience.
Ertas G; Başal FB; Üçer AR; Benzer E; Altundağ MB; Demirci U; Çetin B; Karatas F
J Cancer Res Ther; 2020; 16(6):1229-1234. PubMed ID: 33342778
[TBL] [Abstract][Full Text] [Related]
18. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment.
Aydiner A; Sen F; Tambas M; Ciftci R; Eralp Y; Saip P; Karanlik H; Fayda M; Kucucuk S; Onder S; Yavuz E; Muslumanoglu M; Igci A
Medicine (Baltimore); 2015 Dec; 94(52):e2341. PubMed ID: 26717372
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
Krings G; Chen YY
Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
